tiprankstipranks
Advertisement
Advertisement

OCGN Stock Latest News

Ocugen Advances Late-Stage Gene Therapies, Bolsters Cash Runway
Company AnnouncementsOcugen Advances Late-Stage Gene Therapies, Bolsters Cash Runway
1d ago
8K
OCGN
Ocugen reports Q1 EPS (6c), consensus (5c)
PremiumThe Fly
Ocugen reports Q1 EPS (6c), consensus (5c)
2d ago
OCGN
Ocugen Announces Private Convertible Notes Offering to Deleverage
PremiumCompany Announcements
Ocugen Announces Private Convertible Notes Offering to Deleverage
2d ago
8K
OCGN
Ocugen announces private offering of $115M of convertible senior notes
PremiumThe Fly
Ocugen announces private offering of $115M of convertible senior notes
2d ago
OCGN
Ocugen: Buy Rating Reiterated as Analyst Highlights Retinal Pipeline Upside and Maintains $12 Price Target
PremiumRatings
Ocugen: Buy Rating Reiterated as Analyst Highlights Retinal Pipeline Upside and Maintains $12 Price Target
5d ago
OCGN
OCGN Earnings Report this Week: Is It a Buy, Ahead of Earnings?
PremiumPre-EarningsOCGN Earnings Report this Week: Is It a Buy, Ahead of Earnings?
8d ago
OCGN
Ocugen completes dosing in GARDian3 trial
Premium
The Fly
Ocugen completes dosing in GARDian3 trial
1M ago
OCGN
Chardan sees positive read-through to Annexon’s vonaprument from Apellis deal
Premium
The Fly
Chardan sees positive read-through to Annexon’s vonaprument from Apellis deal
1M ago
ANNX
APLS
Ocugen Updates Roadmap for Gene-Agnostic Retinal Therapies
PremiumCompany Announcements
Ocugen Updates Roadmap for Gene-Agnostic Retinal Therapies
1M ago
8K
OCGN
Ocugen: Encouraging Phase 2 OCU410 Data in Geographic Atrophy Underpin Buy Rating and Long-Term Upside Potential
PremiumRatings
Ocugen: Encouraging Phase 2 OCU410 Data in Geographic Atrophy Underpin Buy Rating and Long-Term Upside Potential
1M ago
OCGN
Ocugen price target raised to $12 from $8 at Noble Capital
PremiumThe Fly
Ocugen price target raised to $12 from $8 at Noble Capital
1M ago
OCGN
Ocugen price target raised to $10 from $7 at H.C. Wainwright
PremiumThe Fly
Ocugen price target raised to $10 from $7 at H.C. Wainwright
1M ago
OCGN
Ocugen Reports Positive Phase 2 Data for OCU410 Therapy
PremiumCompany AnnouncementsOcugen Reports Positive Phase 2 Data for OCU410 Therapy
1M ago
8K
OCGN
Midday Fly By: Estee Lauder in deal talks with Puig, Smithfield reports Q4 beat
Premium
The Fly
Midday Fly By: Estee Lauder in deal talks with Puig, Smithfield reports Q4 beat
1M ago
EL
RL
Ocugen announces 12-month data from ArMaDa clinical trial of OCU410
Premium
The Fly
Ocugen announces 12-month data from ArMaDa clinical trial of OCU410
1M ago
OCGN
TTD, OCGN, STZ, VRTX, LCID Trending With Analysts
PremiumWeekend Updates
TTD, OCGN, STZ, VRTX, LCID Trending With Analysts
2M ago
STZ
TTD
Ocugen Gains $15 Million, Extends Cash Runway to 2027
PremiumCompany Announcements
Ocugen Gains $15 Million, Extends Cash Runway to 2027
2M ago
8K
OCGN
Midday Fly By: Nvidia bullish on AI revenue, MasterCard to acquire BVNK
PremiumThe Fly
Midday Fly By: Nvidia bullish on AI revenue, MasterCard to acquire BVNK
2M ago
BA
BW
Ocugen initiated with a Buy at Canaccord
PremiumThe Fly
Ocugen initiated with a Buy at Canaccord
2M ago
OCGN
Midday Fly By: IEA to release 400M oil barrels, Oracle reports Q3 beat
PremiumThe FlyMidday Fly By: IEA to release 400M oil barrels, Oracle reports Q3 beat
2M ago
MA
TH
Ocugen initiated with an Outperform at Oppenheimer
Premium
The Fly
Ocugen initiated with an Outperform at Oppenheimer
2M ago
OCGN
Ocugen price target raised to $22 from $15 at Lucid Capital
Premium
The Fly
Ocugen price target raised to $22 from $15 at Lucid Capital
2M ago
OCGN

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >